De Wit H
Department of Psychiatry, University of Chicago, IL 60637.
Br J Addict. 1991 Dec;86(12):1579-86. doi: 10.1111/j.1360-0443.1991.tb01751.x.
Drug preference procedures may be used to assess the abuse liability of drugs in human volunteers. These procedures usually measure subjects' choice of a drug versus a placebo, under controlled, double-blind conditions. Depending upon the conditions of the studies (e.g. subject population, environmental conditions of testing), drugs that are known to be abused are also preferred in these laboratory procedures. To assess the abuse liability of an unknown test drug, the frequency of choice of the test drug is compared to choice of a standard drug with known abuse potential: preference for the test drug, relative to the standard, is then taken as an indicator of its relative potential for abuse. A number of methodological variables must be considered when designing and interpreting choice studies, including the characteristics of the subjects, the range of doses tested, whether choices were spaced widely apart (e.g. one a day) or closely together (e.g. one immediately after another), and whether the study was conducted under controlled laboratory conditions or in the subjects' normal daily environments. The conditions for testing the abuse liability of an unknown compound must be selected based on the existing literature with similar, known drugs of abuse.
药物偏好程序可用于评估药物在人类志愿者中的滥用可能性。这些程序通常在受控、双盲条件下测量受试者对药物与安慰剂的选择。根据研究条件(例如受试者群体、测试的环境条件),已知会被滥用的药物在这些实验室程序中也更受青睐。为了评估一种未知测试药物的滥用可能性,将测试药物的选择频率与具有已知滥用潜力的标准药物的选择频率进行比较:相对于标准药物,对测试药物的偏好随后被视为其相对滥用潜力的指标。在设计和解释选择研究时,必须考虑许多方法学变量,包括受试者的特征、测试剂量范围、选择是间隔很远(例如每天一次)还是紧密相连(例如一个紧接着另一个),以及研究是在受控实验室条件下还是在受试者的正常日常环境中进行。必须根据关于类似的已知滥用药物的现有文献来选择测试未知化合物滥用可能性的条件。